Redeye updates its estimates following Vitec’s directed share issue on 09 November 2022. Increased dilution and M&A firepower roughly offset each other in our valuation. We nudge up our projected M&A volumes considering a more significant equity component in the company’s estimated sources of cash.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.